For research use only
| Cat No. | ABC-TC001G |
| Product Type | Intrahepatic Biliary Cells |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Whole Human Livers |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Leverage Human Liver Intrahepatic Biliary Epithelial Cells-Passage 1 for hepatobiliary research, cholangiocyte biology, and liver disease modeling.
Intrahepatic biliary epithelial cells (IBEpiC), also known as Primary Human Cholangiocytes, are derived from whole liver tissue, and line the intrahepatic bile ducts—a network of small ducts within the liver that transport bile. After primary culture, these cells are cryopreserved. Intrahepatic biliary epithelial cells (IBEpiC) are involved in physiological processes such as liver metabolism and excretion. Studies have shown that Intrahepatic biliary epithelial cells (IBEpiC) are related to both innate and adaptive immune responses. Markers for IBEpiC include KRT7, KRT19, CK7, CK19, SOX9, and SPP1. During culture, repeated freezing and thawing should be avoided.
| Species | Human |
| Cat.No | ABC-TC001G |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Whole Human Livers |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Intrahepatic Biliary Cells |
Human IBEpiC cells serve as an in vitro model for studying the pathogenesis of intrahepatic bile duct diseases, which is crucial for improving diagnosis and treatment. Cholangiopathy, a chronic liver disease, includes primary biliary cirrhosis, primary sclerosing cholangitis, polycystic liver disease, and cholangiocarcinoma. Due to the lack of effective medical treatments, cholangiopathy often progresses to end-stage liver disease with high morbidity and mortality. Therefore, studying immune regulation in Human IBEpiC cells will help develop new genetic or pharmacological strategies to treat cholangiopathy. These cells are not suitable for liver transplantation.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).